These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28288641)

  • 1. SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.
    Liu K; Xie F; Gao A; Zhang R; Zhang L; Xiao Z; Hu Q; Huang W; Huang Q; Lin B; Zhu J; Wang H; Que J; Lan X
    Mol Cancer; 2017 Mar; 16(1):62. PubMed ID: 28288641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling.
    Zhu Y; Zhang X; Qi M; Zhang Y; Ding F
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2126-2134. PubMed ID: 31039290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
    Zhai Z; Mu T; Zhao L; Li Y; Zhu D; Pan Y
    Bioengineered; 2022 Jan; 13(1):83-95. PubMed ID: 34951340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2.
    Wang J; Zeng H; Li H; Chen T; Wang L; Zhang K; Chen J; Wang R; Li Q; Wang S
    Cell Physiol Biochem; 2017; 43(2):717-732. PubMed ID: 28946143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT signaling pathway.
    Zhang H; Xu W
    Brain Res; 2021 Aug; 1764():147465. PubMed ID: 33811842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2.
    Tang W; Zhang X; Tan W; Gao J; Pan L; Ye X; Chen L; Zheng W
    J Surg Res; 2019 Apr; 236():278-287. PubMed ID: 30694767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-145-5p attenuates paclitaxel resistance and suppresses the progression in drug-resistant breast cancer cell lines.
    Guan X; Guan Y
    Neoplasma; 2020 Sep; 67(5):972-981. PubMed ID: 32412771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
    Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.
    Yu W; Li D; Zhang Y; Li C; Zhang C; Wang L
    Technol Cancer Res Treat; 2019; 18():1533033819892264. PubMed ID: 31789129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
    Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
    Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-371-5p targets SOX2 in gastric cancer.
    Li YJ; Dong M; Kong FM; Zhou JP; Liang D; Xue HZ
    Oncotarget; 2016 May; 7(22):31993-2005. PubMed ID: 27015119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.
    Zeng H; Wang L; Wang J; Chen T; Li H; Zhang K; Chen J; Zhen S; Tuluhong D; Li J; Wang S
    Arch Biochem Biophys; 2018 Aug; 651():52-60. PubMed ID: 29802821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
    Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
    Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
    Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
    Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
    [No Abstract]   [Full Text] [Related]  

  • 18. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
    Song X; Wang H; Wu J; Sun Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
    Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
    Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
    Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.